Establishment of Detection Systems and Expression Systems for Organ-Specific Mucins

器官特异性粘蛋白检测系统和表达系统的建立

基本信息

  • 批准号:
    05557104
  • 负责人:
  • 金额:
    $ 7.23万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1995
  • 项目状态:
    已结题

项目摘要

The aims of this proposal is to establish systems to detect various human epithelial mucins and to establish systems to obtain stable transfectant cells expressing mucin core polypeptide cDNA.Specifically, preparation of monoclonal antibodies specific for unique mucins and preparation of expression vectors containing mucin core polypeptide cDNA were conducted. Elucidation of the transcriptional regulation of mucin core polypeptides was also performed.The following list consists of the findings obtained during the project term : (1) A novel monoclonal antibody MY.1E12 specific for sialylated MUC1 mucin was established. (2) Vectors containing chimera mucins (MUC1/MMGL and MUC2/MMGL) have been prepared. (3) A stable transfectant cell line and clones have been prepared using human renal carcinoma cells. The biological behavior of these cells were investigated. (4) Glycosylation of MUC1 mucins expressed by transfection of K562 human erythroleukemia cells was compared to the glycosylation of endogenous leukocyte mucins. (5) A lectin expressed by a strain of enterobacterium was isolated and shown to bind MUC2 mucin but not MUC1 mucin. (6) A novel lecting that was isolated from this bacterium. (7) An inducible transcriptional cis-acting element for MUC1 mucin gene has been identified. Binding proteins to this element were isolated from nuclear extracts of mammary carcinoma cells. (8) A cDNA corresponding to human macrophage lectin has been cloned and expressed. The carbohydrate binding specificity of this lectin has been demonstrated to bind to Tn and sialyl-Tn antigens.
本课题的目的是建立检测各种人上皮粘蛋白的系统,并建立获得表达粘蛋白核心多肽cDNA的稳定转染细胞的系统,具体而言,制备特异于独特粘蛋白的单克隆抗体,并制备含有粘蛋白核心多肽cDNA的表达载体。本课题的主要研究结果如下:(1)建立了一种新的唾液酸化MUC 1单克隆抗体MY.1E12。(2)已经制备了含有嵌合粘蛋白(MUC 1/MMGL和MUC 2/MMGL)的载体。(3)已使用人肾癌细胞制备了稳定的转染细胞系和克隆。研究了这些细胞的生物学行为。(4)将通过转染K562人红白血病细胞表达的MUC 1粘蛋白的糖基化与内源性白细胞粘蛋白的糖基化进行比较。(5)分离出一种肠杆菌属菌株表达的凝集素,该凝集素与MUC 2粘蛋白结合,但不与MUC 1粘蛋白结合。(6)从该细菌中分离出一种新的凝集素。(7)MUC 1粘蛋白基因的一个可诱导的转录顺式作用元件已被鉴定。从乳腺癌细胞的核提取物中分离出与该元件结合的蛋白质。(8)克隆并表达了人巨噬细胞凝集素的cDNA。已证明该凝集素的碳水化合物结合特异性结合Tn和唾液酸-Tn抗原。

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Konami, Y.: "A. High degree of sequence homology in the potative carbonydrate recognition domains 〜." Glycobiology. 5. 663-670 (1995)
Konami,Y.:“A. 潜在的羰基化合物识别域中的高度序列同源性〜。糖生物学”。 5. 663-670 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kimura, T., Imai.Y., Irimura: "Calcium-dependent conformation of a mouse macrophage calcium-type lectin" J.Biol.Chem. 270. 16056-16062 (1995)
Kimura, T.、Imai.Y.、Irimura:“小鼠巨噬细胞钙型凝集素的钙依赖性构象”J.Biol.Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakamori,S.: "MUCl mucin explession as a marker of progression and metastasis of human colorectal carcinoma." Gastroenterology. 106. 353-361 (1994)
Nakamori,S.:“MUC1粘蛋白表达作为人类结直肠癌进展和转移的标志。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shirotani,K.: "Transcriptional regclation of MUC1 mucin gene in colon carcinoma cells by a soluble Cactol Identification of a regulatory element" J.Biol.Chem.269. 15030-15035 (1994)
Shirotani,K.:“通过可溶性 Cactol 调节结肠癌细胞中 MUC1 粘蛋白基因的转录调节调节元件的鉴定”J.Biol.Chem.269。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kimura, T.: "Calcium dependent Conformation of a Moose Macrophage Calcium-type lectin." The Jarnal of Biological Chemistry. 270. 16056-16062 (1995)
Kimura, T.:“驼鹿巨噬细胞钙型凝集素的钙依赖性构象。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IRIMURA Tatsuro其他文献

IRIMURA Tatsuro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IRIMURA Tatsuro', 18)}}的其他基金

Development of cancer stem cells driven by microenvironment
微环境驱动的癌症干细胞的发育
  • 批准号:
    26670023
  • 财政年份:
    2014
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
MUC21 glycoforms as the target of cancer diagnosis and therapy
MUC21糖型作为癌症诊断和治疗的靶点
  • 批准号:
    25293011
  • 财政年份:
    2013
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of IgA responses against influenza virus
流感病毒 IgA 反应的调节
  • 批准号:
    24659029
  • 财政年份:
    2012
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
A peptide sequence motif which regulates glycoforms
调节糖型的肽序列基序
  • 批准号:
    22659016
  • 财政年份:
    2010
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Immune-suppressive function of cancer-associated mucin epiglycanin/Muc21
癌症相关粘蛋白表聚糖蛋白/Muc21的免疫抑制功能
  • 批准号:
    21390018
  • 财政年份:
    2009
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Structural diversity of mucins : Significance in infection and immunity
粘蛋白的结构多样性:在感染和免疫中的意义
  • 批准号:
    12307054
  • 财政年份:
    2000
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Establishment of hepatic metastasis model of pancreatic carcinoma and it application to the development of therapeutic agents
胰腺癌肝转移模型的建立及其在治疗药物开发中的应用
  • 批准号:
    11557180
  • 财政年份:
    1999
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of cellular trafficking and pathogenesis by mucins
粘蛋白对细胞运输和发病机制的调节
  • 批准号:
    07407063
  • 财政年份:
    1995
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Cell surface glycoconjugates and adhesion molecules
细胞表面糖复合物和粘附分子
  • 批准号:
    04454591
  • 财政年份:
    1992
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
  • 批准号:
    10892414
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
  • 批准号:
    10932479
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
  • 批准号:
    10674274
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
  • 批准号:
    10761372
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
  • 批准号:
    10711469
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
  • 批准号:
    10933280
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
  • 批准号:
    10696698
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
  • 批准号:
    10726173
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
  • 批准号:
    2212947
  • 财政年份:
    2022
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
  • 批准号:
    22K19387
  • 财政年份:
    2022
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了